XML 121 R70.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisition of Prismic Pharmaceutical - Schedule of identifiable assets acquired and liabilities assumed (Details) - Prismic Pharmaceuticals Inc. ("Prismic")
Jun. 28, 2019
CAD ($)
Disclosure of detailed information about business combination [line items]  
Cash $ 2,329
Prepaids 26,174
Intellectual Property 24,648,915
Trade and other payables (1,867,250)
Short-term notes (195,475)
Notes payable (1,727,484)
Total consideration transferred, acquisition-date fair value $ 20,887,209